EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention

Ko Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Toshihiro Tamura und 11 weitere

JACC: Cardiovascular Interventions · 2024

DOI: 10.1016/j.jcin.2024.03.017 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Ko Yamamoto und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Aspirin, Hemorrhage. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There was no study evaluating the effects of an aspirin-free strategy in patients undergoing complex percutaneous coronary intervention (PCI). OBJECTIVES: The authors aimed to evaluate the efficacy and safety of an aspirin-free strategy in patients undergoing complex PCI. METHODS: We conducted the prespecified subgroup analysis based on complex PCI in the STOPDAPT-3 (ShorT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent-3), which randomly compared low-dose prasugrel (3.75 mg/d) monotherapy to dual antiplatelet therapy (DAPT) with low-dose prasugrel and aspirin in patients with acute coronary syndrome or high bleeding risk. Complex PCI was defined as any of the following 6 criteria: 3 vessels treated, ≥3 stents implanted, ≥3 lesions treated, bifurcation with 2 stents implanted, total stent length >60 mm, or a target of chronic total occlusion. The coprimary endpoints were major bleeding events (Bleeding Academic Research Consortium 3 or 5) and cardiovascular events (a composite of cardiovascular death, myocardial infarction, definite stent thrombosis, or ischemic stroke) at 1 month. RESULTS: Of the 5,966 study patients, there were 1,230 patients (20.6%) with complex PCI. Regardless of complex PCI, the effects of no aspirin relative to DAPT were not significant for the coprimary bleeding (complex PCI: 5.30% vs 3.70%; HR: 1.44; 95% CI: 0.84-2.47; P = 0.18 and noncomplex PCI: 4.26% vs 4.97%; HR: 0.85; 95% CI: 0.65-1.11; P = 0.24; P for interaction = 0.08) and cardiovascular (complex PCI: 5.78% vs 5.93%; HR: 0.98; 95% CI: 0.62-1.55; P = 0.92 and noncomplex PCI: 3.70% vs 3.10%; HR: 1.20; 95% CI: 0.88-1.63; P = 0.25; P for interaction = 0.48) endpoints without significant interactions. CONCLUSIONS: The effects of the aspirin-free strategy relative to standard DAPT for the cardiovascular and major bleeding events were not different regardless of complex PCI. (ShorT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent-3 [STOPDAPT-3]; NCT04609111).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionPlatelet Aggregation InhibitorsAspirinHemorrhageDual Anti-Platelet TherapyPrasugrel HydrochlorideEverolimusDrug-Eluting StentsProsthesis DesignDrug Administration ScheduleCoronary Artery DiseaseHumansMaleTime FactorsFemaleAgedMiddle AgedTreatment OutcomeRisk FactorsCoronary ThrombosisAcute Coronary SyndromeChromium AlloysRisk AssessmentDrug Therapy, Combination

Stichwörter der Autor:innen

antiplatelet therapycomplexitycoronary stentpercutaneous coronary intervention

Substanzen

Platelet Aggregation InhibitorsAspirinPrasugrel HydrochlorideEverolimusChromium Alloys

Autor:innen und Institutionen

  • Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
  • Department of Cardiovascular Medicine, Saga University, Saga, Japan.
  • Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
  • Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.

Zitieren

APA

Yamamoto, K., Natsuaki, M., Watanabe, H., Morimoto, T., Obayashi, Y., Nishikawa, R., Ando, K., Suwa, S., Isawa, T., Takenaka, H., Ishikawa, T., Tamura, T., Kawahatsu, K., Hayashi, F., Akao, M., Serikawa, T., Mori, H., Kawamura, T., Hagikura, A., …, & STOPDAPT-3 Investigators (2024). An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.03.017

Vancouver

Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, et al. An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.03.017

BibTeX
@article{Yamamoto2024,
  author = {Yamamoto, Ko and Natsuaki, Masahiro and Watanabe, Hirotoshi and Morimoto, Takeshi and Obayashi, Yuki and Nishikawa, Ryusuke and Ando, Kenji and Suwa, Satoru and Isawa, Tsuyoshi and Takenaka, Hiroyuki and Ishikawa, Tetsuya and Tamura, Toshihiro and Kawahatsu, Kando and Hayashi, Fujio and Akao, Masaharu and Serikawa, Takeshi and Mori, Hiroyoshi and Kawamura, Takayuki and Hagikura, Arata and Shibata, Naoki and Ono, Koh and Kimura, Takeshi and STOPDAPT-3 Investigators, STOPDAPT-3 Investigators},
  title = {An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention},
  journal = {JACC: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1016/j.jcin.2024.03.017}
}
Kostenlos starten →